Literature DB >> 4246870

Clinical and bacteriological studies with clindamycin.

A M Geddes, F A Bridgwater, D N Williams, J Oon, G J Grimshaw.   

Abstract

Fifty patients have been treated with clindamycin, a chemical analogue of lincomycin. Forty-four responded satisfactorily to treatment. Gastrointestinal side-effects were rare though five patients developed rashes. Most recently isolated staphylococci are clindamycin-sensitive.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4246870      PMCID: PMC1700701          DOI: 10.1136/bmj.2.5711.703

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  2 in total

1.  Comparative studies of antibacterial activity in vitro and absorption and excretion of lincomycin and clinimycin.

Authors:  R F McGehee; C B Smith; C Wilcox; M Finland
Journal:  Am J Med Sci       Date:  1968-11       Impact factor: 2.378

2.  Drug rash with ampicillin and other penicillins.

Authors:  S Shapiro; V Siskind; D Slone; G P Lewis; H Jick
Journal:  Lancet       Date:  1969-11-08       Impact factor: 79.321

  2 in total
  23 in total

Review 1.  Clindamycin--efficacy and toxicity.

Authors:  R I Frankel
Journal:  West J Med       Date:  1975-06

2.  [Not Available].

Authors:  P Auger; P Ricard; J Carre
Journal:  Can Fam Physician       Date:  1972-02       Impact factor: 3.275

3.  Effect of peritoneal dialysis on serum levels of tobramycin and clindamycin.

Authors:  R F Malacoff; F O Finkelstein; V T Andriole
Journal:  Antimicrob Agents Chemother       Date:  1975-11       Impact factor: 5.191

4.  Parenteral clindamycin phosphate: pharmacology with normal and abnormal liver function and effect on nasal staphylococci.

Authors:  D N Williams; K Crossley; C Hoffman; L D Sabath
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

5.  Lincomycin and clindamycin: their role in chemotherapy of anaerobic and microaerophilic infections.

Authors:  G M Savage
Journal:  Infection       Date:  1974       Impact factor: 3.553

6.  A studyof the pharmacokinetics of clidamycin in normal subjects and patients with chronic renal failure.

Authors:  J B Eastwood; P E Gower
Journal:  Postgrad Med J       Date:  1974-11       Impact factor: 2.401

7.  Parenteral and oral clindamycin therapy in surgical infections: a preliminary report.

Authors:  H T Edmondson
Journal:  Ann Surg       Date:  1973-11       Impact factor: 12.969

8.  Clindamycin levels in sputum in a patient with purulent chest disease due to cystic fibrosis.

Authors:  J A Raeburn; J D Devine
Journal:  Postgrad Med J       Date:  1971-06       Impact factor: 2.401

9.  Efficacy of intravenous clindamycin and methicillin in gram-positive soft tissue infections.

Authors:  K C Chessick; L A Begley; L E Curtis; E F Hirsch; C W Kaiser; C A Burek; H S Soroff
Journal:  Ann Surg       Date:  1975-02       Impact factor: 12.969

10.  HLA-B*51:01 is strongly associated with clindamycin-related cutaneous adverse drug reactions.

Authors:  Y Yang; S Chen; F Yang; L Zhang; G Alterovitz; H Zhu; J Xuan; X Yang; H Luo; J Mu; L He; X Luo; Q Xing
Journal:  Pharmacogenomics J       Date:  2016-08-16       Impact factor: 3.550

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.